Integra Lifesciences Holdings Corp revenue by segment IART

Annual Quarterly

Integra Lifesciences Holdings Corp splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was Specialty Surgery at $1.2 billion, 73% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Neurosurgery at $827.7 million, 51% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016
Revenue	1,657	1,635	1,611	1,542	1,558	1,542	1,372	1,518	1,472	—	—
Operating segments
Specialty Surgery	1,220 +2.3% share 73.6%	1,201 +5.0% share 73.4%	1,144 +8.0% share 71.0%	1,059 +3.9% share 68.7%	1,020 -0.6% share 65.5%	1,025 +14.6% share 66.5%	895 -10.2% share 65.2%	996 +3.3% share 65.6%	964 +33.8% share 65.5%	720	—
Tissue Reconstruction	437 -3.1% share 26.4%	435 -6.9% share 26.6%	467 -3.3% share 29.0%	483 -10.3% share 31.3%	538 +4.0% share 34.5%	517 +8.4% share 33.5%	477 -8.5% share 34.8%	521 share 34.4%	—	—	—
Sales mix
Neurosurgery	—	828 +3.0% share 50.6%	804 -1.7% share 49.9%	818 +3.0% share 53.1%	794 -1.1% share 51.0%	803 +12.1% share 52.1%	716 -6.7% share 52.2%	768 +12.2% share 50.6%	684 +53.1% share 46.5%	447	—
Regenerative Skin And Wound	—	323 -7.7% share 19.8%	351 -6.3% share 21.8%	374 -8.0% share 24.3%	407 +3.6% share 26.1%	392 +33.9% share 25.4%	293 -9.2% share 21.4%	323 +3.6% share 21.3%	312 +13.5% share 21.2%	274	—
Instruments	—	206 +1.1% share 12.6%	204 +0.3% share 12.7%	204 -9.7% share 13.2%	226 +1.5% share 14.5%	222 +24.5% share 14.4%	178 -21.9% share 13.0%	228 -18.4% share 15.1%	280 +2.4% share 19.0%	273	—
ENT	—	166 +22.7% share 10.2%	136 +263.9% share 8.4%	37 +13.4% share 2.4%	33 share 2.1%	—	—	—	—	—	—
Private Label	—	111 -4.4% share 6.8%	116 +7.1% share 7.2%	109 -17.4% share 7.0%	131 +5.3% share 8.4%	125 +18.0% share 8.1%	106 -2.6% share 7.7%	109 +2.0% share 7.2%	106 +6.4% share 7.2%	100	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: IART (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Princeton, NJ
SEC filer status: Large accelerated filer
SEC CIK: 917520
Former names: INTEGRA LIFESCIENCES CORP (until Mar 31, 1999)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.